We work at the convergence of science, medicine, and engineering to reinvent the process of drug discovery and treatment.

The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.

 

Our faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research, and computer science to accelerate the invention of the life-saving medicines and precision diagnostics that are needed to optimally treat individual patients.

 

HiTS brings together two approaches:

The Laboratory of Systems Pharmacology makes it possible to study the changes that promote disease and the ways in which therapeutic drugs function at the molecular level.

The Center for Regulatory Science focuses on evaluating drugs in clinical trials and balancing the benefits and risks of new medicines.

News, Events, & Updates

Regulatory Science Forum

Opportunities for Large Language Models in Regulatory Science

Dr. Tim Miller, Computational Health Informatics Program (CHIP), Boston Children’s Hospital 

Tuesday, September 17th, 12:00pm ET

Register here!

LSP in the News

A Step Toward New Solutions for Inflammatory Pain

Read the article 

HiTS in the News

Seeing the Human Behind the Data

Read the article